Press release
Medpace Holdings, Inc. (NASDAQ: MEDP) Investor Alert: Deadline in Lawsuit on June 8, 2026
A Deadline is coming up on June 8, 2026 in the lawsuit for certain investors in Medpace Holdings, Inc. (NASDAQ: MEDP).
Investors who purchased shares of Medpace Holdings, Inc. (NASDAQ: MEDP) have certain options and there are strict and short deadlines running. Deadline: June 8, 2026. Medpace Holdings, Inc. (NASDAQ: MEDP) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Cincinnati, OH based Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
On February 9, 2026, Medpace released fourth quarter 2025 earnings results revealing a book-to-bill ratio of 1.04, well below Medpace's guidance. Medpace Holdings, Inc. (NASDAQ: MEDP) reported that its annual Total Revenue rose from over $2.1 billion in 2024 to over $2.5 billion in 2025 and that its Net Income increased from $404.38 million in 2024 to $451.12 million in 2025.
Shares of Medpace Holdings, Inc. (NASDAQ: MEDP) declined from $628.92 per share on January 16, 2026, to $392.35 per share on February 12, 2026.
According to the complaint filed in the U.S. District Court for the Southern District of Ohio the plaintiff alleges on behalf of purchasers of Medpace Holdings, Inc. (NASDAQ: MEDP) common shares between April 22, 2025 and February 9, 2026, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between April 22, 2025 and February 9, 2026, the defendants made false and/or misleading statements and/or failed to disclose that Medpace consistently oversold Medpace's projected book-to-bill ratio for fourth quarter 2025, that Medpace knew or recklessly disregarded the impact that cancellations have on Medpace's book-to-bill ratio, that Medpace frequently claimed that the projection of a 1.15 book-to-bill ratio for fourth quarter 2025 was reasonable and achievable and that cancellations were not a sign of a weak business environment,that Medpace reassured investors that Medpace was not concerned about the lack of diversity in its pre-backlog, and that Medpace management stated that, despite the uptick in metabolic growth, Medpace's upside was broad-based and not isolated to any handful of studies.
Those who purchased shares of Medpace Holdings, Inc. (NASDAQ: MEDP) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Medpace Holdings, Inc. (NASDAQ: MEDP) Investor Alert: Deadline in Lawsuit on June 8, 2026 here
News-ID: 4542846 • Views: …
More Releases from Shareholders Foundation
SES AI Corporation (NYSE: SES) Investor Alert: Deadline in Lawsuit on June 26, 2 …
A deadline is coming up on June 26, 2026 in the lawsuit filed for certain investors of SES AI Corporation (NYSE: SES) over alleged securities laws violations by SES AI Corporation.
Investors who purchased shares of SES AI Corporation (NYSE: SES) have certain options and there are strict and short deadlines running. Deadline: June 26, 2026. SES AI Corporation (NYSE: SES) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call…
Lawsuit filed for Investors who lost money with shares of Enphase Energy, Inc. ( …
An investor, who purchased shares of Enphase Energy, Inc. (NASDAQ: ENPH), filed a lawsuit over alleged violations of Federal Securities Laws by Enphase Energy, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Enphase Energy, Inc. (NASDAQ: ENPH) have certain options and for certain investors are short and strict deadlines running. Deadline: April 20, 2026. NASDAQ: ENPH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Investigation announced for Long-Term Investors in shares of Fiserv, Inc. (NYSE: …
An investigation was announced for current long-term investors in shares of Fiserv, Inc. (NYSE: FI) concerning potential breaches of fiduciary duties by certain directors and officers of Fiserv, Inc.
Investors who are current long term investors in Fiserv, Inc. (NYSE: FI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Ardent Health, Inc. (NYSE: ARDT) Investor Alert: Deadline in Lawsuit on March 09 …
A deadline is coming up on March 09, 2026 in the lawsuit filed for certain investors of Ardent Health, Inc. (NYSE: ARDT) over alleged securities laws violations by Ardent Health, Inc.
Investors who purchased shares of Ardent Health, Inc. (NYSE: ARDT) have certain options and there are strict and short deadlines running. Deadline: March 09, 2026. Ardent Health, Inc. (NYSE: ARDT) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or…
More Releases for Medpace
Life Sciences Contract Research Outsourcing Market to Witness Stunning Growth wi …
HTF MI just released the Global Life Sciences CRO Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major companies profiled in Life Sciences CRO Market are:
IQVIA, LabCorp,…
Cell Banking Outsourcing Market to See Sustainable Growth Ahead: Lonza Group, Wu …
The Latest Released Global Cell Banking Outsourcing market study has evaluated the future growth potential of Global Cell Banking Outsourcing market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision-makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, and emerging trends along…
Pharmaceutical Contract Research and Manufacturing Market Is Booming Worldwide w …
The "Global Pharmaceutical Contract Research and Manufacturing" intelligence report, just published by USD Analytics, covers insurers' micro-level study of important market niches, product offers, and sales channels. In order to determine market size, potential, growth trends, and competitive environment, the Global Pharmaceutical Contract Research and Manufacturing provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several…
Healthcare Contract Research Outsourcing Market May See a Big Move | Syneos Heal …
Advance Market Analytics published a new research publication on "Healthcare Contract Research Outsourcing Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Healthcare Contract Research Outsourcing market was mainly driven by the increasing R&D spending across the world.
Some of the…
Pharmacovigilance Market May See a Big Move | Ennov Solutions, Medpace, BioSourc …
Latest Study on Industrial Growth of Pharmacovigilance Market 2023-2028. A detailed study accumulated to offer Latest insights about acute features of the Pharmacovigilance market. The report contains different market predictions related to revenue size, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the…
Clinical Trial Imaging Services Market Size Is Going To Boom | Median Technologi …
The document highlights several factors of the Clinical Trial Imaging Services Market, such as market definition, market segmentation, opposition analysis, and lookup methodology. Additionally, it affords records about market forces and constraints that assist agencies make knowledgeable guesses about whether or not to expand or reduce the manufacturing of a positive product.
The clinical trial imaging services market accounted for $1,310 million in 2019, and is expected to reach $1,807.65 million…
